Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THOR

Synthorx (THOR) Stock Price, News & Analysis

Synthorx logo

About Synthorx Stock (NASDAQ:THOR)

Key Stats

Today's Range
$67.99
$67.99
50-Day Range
$67.99
$67.99
52-Week Range
$11.05
$71.90
Volume
N/A
Average Volume
474,507 shs
Market Capitalization
$2.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive THOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synthorx and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THOR Stock News Headlines

October 16 Changes the Microchip Game — and Investing
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
Biosimilar Interleukins Global Market Report 2023
See More Headlines

THOR Stock Analysis - Frequently Asked Questions

Synthorx, Inc. (NASDAQ:THOR) issued its quarterly earnings results on Tuesday, November, 5th. The medical instruments supplier reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.50) by $0.12.

Synthorx (THOR) raised $100 million in an initial public offering on Friday, December 7th 2018. The company issued 9,100,000 shares at a price of $10.00-$12.00 per share. Jefferies, Leerink Partners and Evercore ISI served as the underwriters for the IPO and H.C. Wainwright & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synthorx investors own include Pfizer (PFE), NVIDIA (NVDA), Gilead Sciences (GILD), Meta Platforms (META), Alibaba Group (BABA), Tesla (TSLA) and Salesforce (CRM).

Company Calendar

Last Earnings
11/05/2019
Today
10/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:THOR
CIK
350907
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.61 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.09%
Return on Assets
-24.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
18.87
Quick Ratio
18.87

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.72 per share
Price / Book
10.12

Miscellaneous

Outstanding Shares
32,338,000
Free Float
N/A
Market Cap
$2.20 billion
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:THOR) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners